Press Release

Illumina to Webcast Live Presentation at the Morgan Stanley Global Healthcare Conference

SAN DIEGO--(BUSINESS WIRE)--Sep. 3, 2015-- Illumina, Inc. (NASDAQ: ILMN) today announced that it will webcast the Company’s presentation at the Morgan Stanley Global Healthcare Conference in New York on September 17, 2015. The live webcast is scheduled to begin at 2:05 PM ET and will feature an overview of the company by Jay Flatley, Chief Executive Officer, followed by a question and answer session.

The webcast can be accessed in the Investor Relations section of Illumina's web site under the "Company" tab at www.illumina.com.

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit www.illumina.com and follow @illumina.

Source: Illumina, Inc.

Illumina, Inc.
Investors:
Rebecca Chambers, 858-255-5243
rchambers@illumina.com
or
Media:
Jennifer Temple, 858-882-6822
pr@illumina.com

Recent articles

Professor Emma Baple on bringing whole-genome sequencing into clinical research
Video: Professor Emma Baple on bringing whole-genome sequencing into clinical research
What is proteomics? A simple guide to understanding measuring proteins at scale
What is proteomics? A simple guide to understanding measuring proteins at scale
When sequencing isn’t enough: A global forum for finding answers
When sequencing isn’t enough: A global forum for finding answers